Bacteriophage Procurement for Therapeutic Purposes
- PMID: 27570518
- PMCID: PMC4981656
- DOI: 10.3389/fmicb.2016.01177
Bacteriophage Procurement for Therapeutic Purposes
Erratum in
-
Corrigendum: Bacteriophage Procurement for Therapeutic Purposes.Front Microbiol. 2016 Nov 9;7:1813. doi: 10.3389/fmicb.2016.01813. eCollection 2016. Front Microbiol. 2016. PMID: 27833608 Free PMC article.
Abstract
Bacteriophages (phages), discovered 100 years ago, are able to infect and destroy only bacterial cells. In the current crisis of antibiotic efficacy, phage therapy is considered as a supplementary or even alternative therapeutic approach. Evolution of multidrug-resistant and pandrug-resistant bacterial strains poses a real threat, so it is extremely important to have the possibility to isolate new phages for therapeutic purposes. Our phage laboratory and therapy center has extensive experience with phage isolation, characterization, and therapeutic application. In this article we present current progress in bacteriophages isolation and use for therapeutic purposes, our experience in this field and its practical implications for phage therapy. We attempt to summarize the state of the art: properties of phages, the methods for their isolation, criteria of phage selection for therapeutic purposes and limitations of their use. Perspectives for the use of genetically engineered phages to specifically target bacterial virulence-associated genes are also briefly presented.
Keywords: antibiotic resistance; bacteriophage isolation; experimental phage therapy; therapeutic phages; treatment of bacterial infections.
Figures
Similar articles
-
Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.BioDrugs. 2021 May;35(3):255-280. doi: 10.1007/s40259-021-00480-z. Epub 2021 Apr 21. BioDrugs. 2021. PMID: 33881767 Free PMC article. Review.
-
Phage Resistance in Multidrug-Resistant Klebsiella pneumoniae ST258 Evolves via Diverse Mutations That Culminate in Impaired Adsorption.mBio. 2020 Jan 28;11(1):e02530-19. doi: 10.1128/mBio.02530-19. mBio. 2020. PMID: 31992617 Free PMC article.
-
Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review.Int J Antimicrob Agents. 2019 Jan;53(1):16-21. doi: 10.1016/j.ijantimicag.2018.09.004. Epub 2018 Sep 17. Int J Antimicrob Agents. 2019. PMID: 30236954 Review.
-
Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.J Antimicrob Chemother. 2014 Sep;69(9):2326-36. doi: 10.1093/jac/dku173. Epub 2014 May 28. J Antimicrob Chemother. 2014. PMID: 24872344 Review.
-
Manufacturing of bacteriophages for therapeutic applications.Biotechnol Adv. 2021 Jul-Aug;49:107758. doi: 10.1016/j.biotechadv.2021.107758. Epub 2021 Apr 22. Biotechnol Adv. 2021. PMID: 33895333 Review.
Cited by
-
Mutant and Recombinant Phages Selected from In Vitro Coevolution Conditions Overcome Phage-Resistant Listeria monocytogenes.Appl Environ Microbiol. 2020 Oct 28;86(22):e02138-20. doi: 10.1128/AEM.02138-20. Print 2020 Oct 28. Appl Environ Microbiol. 2020. PMID: 32887717 Free PMC article.
-
The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.BMC Microbiol. 2018 Aug 31;18(1):97. doi: 10.1186/s12866-018-1234-4. BMC Microbiol. 2018. PMID: 30170558 Free PMC article.
-
The Perfect Bacteriophage for Therapeutic Applications-A Quick Guide.Antibiotics (Basel). 2019 Aug 23;8(3):126. doi: 10.3390/antibiotics8030126. Antibiotics (Basel). 2019. PMID: 31443585 Free PMC article. Review.
-
Growing Trend of Fighting Infections in Aquaculture Environment-Opportunities and Challenges of Phage Therapy.Antibiotics (Basel). 2020 Jun 4;9(6):301. doi: 10.3390/antibiotics9060301. Antibiotics (Basel). 2020. PMID: 32512805 Free PMC article. Review.
-
The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies.Viruses. 2021 Jun 29;13(7):1268. doi: 10.3390/v13071268. Viruses. 2021. PMID: 34209836 Free PMC article. Review.
References
-
- Ackermann H. W. (2005). “Bacteriophage classification,” in Bacteriophages: Biology and Applications eds Kutter E., Sulakvelidze A. (Boca Raton, FL: CRC Press; ) 169–187.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources